StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.93−0.02 (-2.30%)

Close on Nov 20, 2026Market cap $89.63MP/E –Yield –

Zura Bio cash

Cash and short-term investments held at the end of each period.

Zura Bio's cash was $187.65M at Sep 30, 2026. For fiscal 2025 it was $109.41M, up 61887.7% from the year before. The highest annual figure on record is $109.41M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$109.41M+61887.7%
FY2024Dec 31, 2024$176.50K-99.8%
FY2023Dec 31, 2023$99.81M+6269.2%
FY2022Dec 31, 2022$1.57M+114.9%
FY2021Dec 31, 2021$729.22K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$187.65M+134884.9%
Q2 FY2026Jun 30, 2026$205.13M+132681.4%
Q1 FY2026Mar 31, 2026$225.59M+32.3%
Q4 FY2025Dec 31, 2025$109.41M+61887.7%
Q3 FY2025Sep 30, 2025$139.02K-99.9%
Q2 FY2025Jun 30, 2025$154.49K-99.9%
Q1 FY2025Mar 31, 2025$170.57M+89.9%
Q4 FY2024Dec 31, 2024$176.50K-99.8%
Q3 FY2024Sep 30, 2024$188.22M+81.2%
Q2 FY2024Jun 30, 2024$188.44M+67.1%
Q1 FY2024Mar 31, 2024$89.82M+104.3%
Q4 FY2023Dec 31, 2023$99.81M+6269.2%
Q3 FY2023Sep 30, 2023$103.86M+3306.3%
Q2 FY2023Jun 30, 2023$112.80M+2456.7%
Q1 FY2023Mar 31, 2023$43.96M+831.4%
Q4 FY2022Dec 31, 2022$1.57M+114.9%
Q3 FY2022Sep 30, 2022$3.05M+209.0%
Q2 FY2022Jun 30, 2022$4.41M+17565.0%
Q1 FY2022Mar 31, 2022$4.72M+18798.9%
Q4 FY2021Dec 31, 2021$729.22K–
Q3 FY2021Sep 30, 2021$986.65K–
Q2 FY2021Jun 30, 2021$24.98K–
Q1 FY2021Mar 31, 2021$24.98K–

More Zura Bio figures

See a number that looks wrong?